首页> 外文期刊>American Journal of Physiology >Gene therapy of Cav1.2 channel with VIP and VIP receptor agonists and antagonists: a novel approach to designing promotility and antimotility agents
【24h】

Gene therapy of Cav1.2 channel with VIP and VIP receptor agonists and antagonists: a novel approach to designing promotility and antimotility agents

机译:VIP和VIP受体激动剂和拮抗剂对Cav1.2通道进行基因治疗:设计促进运动和抗运动药物的新方法

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

ion channels play a critical role in regulating cellular functions in excitable cells. Defects in ion channel function (ctian-nelopathy) contribute to diseases, such as muscular dystrophy, multiple sclerosis, and motility dysfunction in gut inflammation (4, 25, 39, 42). Channelopathy may result from gene mutation or epigenetic dysfunction resulting in deregulation of gene transcription (46). The microenvironmental stimuli, such as hormones, inflammatory mediators, neurotransmitters, and growth factors regulate the constitutive transcription of several genes to maintain normal cellular function (15, 23, 26, 33, 38, 40). Consequently, alterations in cellular microenvironment may cause transcriptional channelopathy and cellular dysfunction.
机译:离子通道在调节可兴奋细胞的细胞功能中起关键作用。离子通道功能缺陷(ctian-nelopathy)会导致疾病,例如肌肉营养不良,多发性硬化症和肠道炎症中的运动功能障碍(4、25、39、42)。通道病可能是由于基因突变或表观遗传功能障碍导致基因转录失调所致(46)。微环境刺激物,例如激素,炎性介质,神经递质和生长因子,调节几种基因的组成型转录,以维持正常的细胞功能(15、23、26、33、38、40)。因此,细胞微环境的改变可能引起转录通道疾病和细胞功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号